ManagedCareCGM

This site is intended for managed care professionals in the U.S.

This site is intended for managed care professionals in the U.S.

Professionals in Canada should visit CanadaCGM.com

Continuous Glucose Monitoring

Education for Managed Care, Pharmacy, and Payer Professionals

Real-Time Continuous Glucose Monitor (RTCGM) Use Associated with Decreased Diabetes Medical Costs for Patients with Type 2 Diabetes (T2D)

Return to Resources *Product Comparison AMCP Formulary Dossiers Clinical Studies Coverage and Benefit Design Featured Resources Health Economics and Outcomes Research (HEOR) Non-CE Education Resources Professional Guidelines Real-World Evidence Review Articles
Tags: ,

Source: ADA Diabetes June 2021

Key Takeaway: A retrospective analysis of administrative claims data from the Optum Research Database showed rtCGM use was associated with diabetes-related medical cost reductions in patients with T2D. Increased access to rtCGM for patients with T2D may help to reduce diabetes-related cost of care.

Diabetes-related Medical Care Costs Decreased $424 PPPM After Initiating rtCGM Treatment

Real-Time Continuous Glucose Monitor (RTCGM) Use Associated with Decreased Diabetes Medical Costs for Patients with Type 2 Diabetes (T2D)

*PPPM = per patient per month

Click here to access the abstract

Provided by

Provided by

 

This web site is supported by an educational grant from DexCom, Inc.